India Drug Regulator To Encourage Whistleblowers, Add To Port Testing
This article was originally published in PharmAsia News
Executive Summary
India's Central Drugs Standard Control Organization plans to bolster its policy for encouraging whistleblowers in the pharmaceutical industry to disclose information about "spurious drugs," according to an official.